ACTIVE

LD-Oncologic

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
39,6 k €
+14.0% YoY
Gross margin
69,3 k €
+11.0% YoY
Equity
140,3 k €
+23.7% YoY

What does LD-Oncologic do?

LD-Oncologic is a Private limited company incorporated in 2013. Its registered office is in Onhaye.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0533.702.512
Incorporation
26/04/2013
Legal form
Private limited company
Registered office
Rue des Ecoles 7
5520 Onhaye · WallonieSee on map
Contributed capital
12 400,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 13 financial years

2025202420232022202120202019201820172016201520142013
Income statement
Gross margin69,3 k €62,5 k €23,7 k €41 k €48,5 k €56,5 k €45,9 k €66,8 k €59,4 k €52,5 k €60,2 k €-54,1 k €50,6 k €
EBITDA67,7 k €58,7 k €18,1 k €40,1 k €47,4 k €55,8 k €45,2 k €65,7 k €57,9 k €51,7 k €59,5 k €-54,8 k €49 k €
Operating result62,2 k €55,3 k €12,5 k €20 k €27,4 k €24,2 k €13,6 k €34,1 k €25,2 k €22,7 k €30,5 k €-84,2 k €27 k €
Net result39,6 k €34,7 k €7,7 k €11,9 k €17,2 k €14,9 k €5,7 k €22,1 k €19,8 k €16,7 k €23,1 k €-90,5 k €17,7 k €
Balance sheet
Equity140,3 k €113,5 k €78,7 k €71 k €59,1 k €41,9 k €27 k €21,4 k €-714 €-20,6 k €-37,3 k €-60,4 k €30,1 k €
Total assets268,5 k €244,2 k €93,1 k €97,9 k €112,3 k €122 k €140,2 k €179,1 k €203,6 k €196,9 k €226,5 k €259,5 k €279,7 k €
Cash39,5 k €15,9 k €17,9 k €27,4 k €26,4 k €16,8 k €5,1 k €7 k €7 k €7,2 k €7 k €9,8 k €7,3 k €
Debts128,1 k €130,8 k €14,4 k €26,9 k €53,3 k €80,1 k €113,2 k €157,8 k €204,3 k €217,4 k €263,7 k €319,9 k €249,6 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

CHRISTOPHE LONCHAY

Director

Active
VIRGINIE DI SILVERIO

Director

Active

Ended mandates

Christophe LONCHAY

Mandate

Ended
Christophe LONCHAY

Manager

Ended
Virginie DI SILVERIO

Mandate

Ended
Virginie DI SILVERIO

Manager

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date15/07/202620/08/202530/08/202429/08/202325/08/202226/08/2021
General meeting27/06/202628/06/202529/06/202424/06/202325/06/202226/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

13 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202527/06/202615/07/2026FrenchPDF
Micro model31/12/202428/06/202520/08/2025FrenchPDF
Micro model31/12/202329/06/202430/08/2024FrenchPDF
Micro model31/12/202224/06/202329/08/2023FrenchPDF
Micro model31/12/202125/06/202225/08/2022FrenchPDF
Micro model31/12/202026/06/202126/08/2021FrenchPDF
Micro model31/12/201927/06/202014/07/2020FrenchPDF
Micro model31/12/201829/06/201911/07/2019FrenchPDF
Micro model31/12/201730/06/201803/07/2018FrenchPDF
Micro model31/12/201624/06/201728/07/2017FrenchPDF
Abridged model31/12/201525/06/201615/07/2016FrenchPDF
Abridged model31/12/201427/06/201531/07/2015FrenchPDF
Abridged model31/12/201328/06/201428/08/2014FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

CHRISTOPHE LONCHAY

Director

Active
VIRGINIE DI SILVERIO

Director

Active

Ended mandates

Christophe LONCHAY

Mandate

Ended
Christophe LONCHAY

Manager

Ended
Virginie DI SILVERIO

Mandate

Ended
Virginie DI SILVERIO

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates04/01/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DENOMINATION - OBJET - DEMISSIONS, NOMINATIONS
    PDF
  • Other11/07/2013
    DIVERS
    PDF
  • Other30/04/2013
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202539,6 k €↑
  2. 2024
    Annual accounts 202434,7 k €↑
  3. 2023
    Annual accounts 20237,7 k €↓
  4. 2023
    Name changeLD-Oncologic
  5. 2022
    Annual accounts 202211,9 k €↓
  6. 2021
    Annual accounts 202117,2 k €↑
  7. 2021
    Name changeDocteur Christophe LONCHAY
  8. 2020
    Annual accounts 202014,9 k €↑
  9. 2019
    Annual accounts 20195,7 k €↓
  10. 2018
    Annual accounts 201822,1 k €↑
  11. 2017
    Annual accounts 201719,8 k €↑
  12. 2016
    Annual accounts 201616,7 k €↓
  13. 2015
    Annual accounts 201523,1 k €↑
  14. 2014
    Annual accounts 2014-90,5 k €↓
  15. 2013
    Annual accounts 201317,7 k €
  16. 26/04/2013
    IncorporationPrivate limited company